SEC 13F Intelligence

Altium Capital Management LLC / NEO

Altium Capital Management LLC’s Neogenomics Inc Position

Does Altium Capital Management LLC own Neogenomics Inc (NEO)? Not currently — the last reported position was 240.0K shares worth $4M in Q1 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q1 2023
Shares
240.0K
% of Portfolio
+2.32%
Quarters Held
2
position exited

Position History NEO

Reported value by quarter
Q4 ’22: $3MQ4 ’22Q1 ’23: $4MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2023240.0K$4M+2.32%
Q4 2022285.0K$3M+1.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of NEO.